Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

5.22USD
15 Oct 2018
Change (% chg)

$0.02 (+0.38%)
Prev Close
$5.20
Open
$5.15
Day's High
$5.28
Day's Low
$4.98
Volume
129,128
Avg. Vol
141,624
52-wk High
$10.70
52-wk Low
$4.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.36 -0.595
Mar '18 0.15 -0.683
FY 2017 Dec '17
Sep '17 0.13 -0.706
Jun '17 0.00 -0.739
Mar '17 0.13 -0.805
FY 2016 Dec '16 0.08 -0.737
Sep '16 0.11 -0.657
Jun '16 0.10 -0.613
Mar '16 0.09 -0.561
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 1.19 5.43 0.00 0.01
Quarter Ending Mar-19 1 2.70 2.70 2.70 --
Year Ending Dec-18 5 1.75 5.95 0.50 0.60
Year Ending Dec-19 5 2.86 10.80 0.00 18.08
Earnings (per share)
Quarter Ending Dec-18 5 -0.59 -0.43 -0.76 -0.73
Quarter Ending Mar-19 2 -0.55 -0.53 -0.56 --
Year Ending Dec-18 5 -2.44 -2.26 -2.68 -2.95
Year Ending Dec-19 5 -2.43 -2.03 -3.27 -2.82
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.91 32.75
P/E High - Last 5 Yrs. -- 301.66 45.42
P/E Low - Last 5 Yrs. -- 92.42 24.25
Beta -- 0.93 0.89
Price to Sales (TTM) 1,169.61 115.65 5.74
Price to Book (MRQ) 3.08 15.58 5.00
Price to Tangible Book (MRQ) 3.08 14.67 6.57
Price to Cash Flow (TTM) -- 73.07 23.28
% Owned Institutions 57.02 14.71 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.25 1.52
Dividend 5 Year Growth Rate -- 1.73 5.24
Payout Ratio(TTM) -- 16.54 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 413.24 8.00
Sales (TTM) vs TTM 1 Yr. Ago 13.73 79.21 5.62
Sales - 5 Yr. Growth Rate -- 32.28 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -20.53 27.96 20.60
EPS (TTM) vs TTM 1 Yr. Ago -26.74 -- --
EPS - 5 Yr. Growth Rate -- 40.04 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.58 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 8.34 5.19 3.03
LT Debt to Equity (MRQ) 22.22 35.49 12.55
Total Debt to Equity (MRQ) 25.02 37.32 16.89
Interest Coverage (TTM) -- -102.94 32.71

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.99 54.34
Gross Margin - 5 Yr. Avg. -- 50.37 52.13
EBITD Margin (TTM) -24,512.38 -- --
EBITD - 5 Yr. Avg -- -605.43 10.68
Operating Margin (TTM) -25,442.11 -764.71 4.33
Operating Margin - 5 Yr. Avg. -- -626.59 6.11
Pre-Tax Margin (TTM) -26,033.13 -738.48 5.20
Pre-Tax Margin - 5 Yr. Avg. -- -632.35 6.52
Net Profit Margin (TTM) -26,033.13 -739.84 1.49
Net Profit Margin - 5 Yr. Avg. -- -635.37 2.79
Effective Tax Rate (TTM) -- 23.37 23.12
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,936 23,344,613 859,711,668
Net Income/Employee (TTM) -764,427 3,159,253 101,129,378
Receivable Turnover (TTM) 0.98 20.76 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.94 -0.24 11.13
Return on Assets - 5 Yr. Avg. -- 3.46 12.40
Return on Investment (TTM) -56.99 1.70 14.60
Return on Investment - 5 Yr. Avg. -- 2.51 16.13
Return on Equity (TTM) -67.22 3.17 16.33
Return on Equity - 5 Yr. Avg. -- 3.37 17.39
  1 Year 3 Year 5 Year
Sales % 37.59 -41.53 --
EPS (TTM) % -39.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellicum Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.25 9.34 99 52
13 Week -2.82 -7.55 89 64
26 Week -6.65 -13.75 90 77
52 Week -43.96 -52.50 40 50
YTD -16.52 -26.69 59 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 48.47%
# of Holders: 151
Total Shares Held: 25,591,864
3 Mo. Net Change: -754,821
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 9
# Reduced Positions: 7
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.